Bristol-Myers Squibb Company (NYSE: BMY), New Brunswick, NJ – FDA Inspections
Inspection records and compliance data for Bristol-Myers Squibb Company in New Brunswick, New Jersey. 6 FDA inspections on record, last inspected December 12, 2025. Publicly traded as NYSE: BMY.
This profile covers Bristol-Myers Squibb Company based in New Brunswick, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 6
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Unclassified
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected November 20, 2008. Last inspected December 12, 2025.
Most cited issue areas
- Calibration/Inspection/Checking not done1 inspection
FDA inspections (6)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 12, 2025 | Not classified | Human Drugs | 1299176 |
| December 1, 2023 | Not classified | Human Drugs | 1228554 |
| October 13, 2017 | Not classified | Human Drugs | 1034312 |
| November 22, 2013 | NAI | Human Drugs · Drug Quality Assurance | 857661 |
| March 22, 2010 | NAI | Human Drugs · Drug Quality Assurance | 652918 |
| November 20, 2008 | VAI | Human Drugs · Drug Quality Assurance | 547474 |
No Form 483s, Warning Letters or EIRs on record.
Companies with similar regulatory profiles, compliance history, and operations.
Name
Bristol-Myers Squibb Company
Stock ticker
BMY
Exchange
NYSE
Share price
$63.24
Market cap
$129.3B
Price as of
November 6, 2026
FEI Number
2211101
Address
1 Squibb Dr, New Brunswick, New Jersey 08901, United States
Country
United States
ID: 485fabe1-4ba4-46ef-b997-6467e4c074a1